188 related articles for article (PubMed ID: 24434863)
1. A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages.
Gentien D; Kosmider O; Nguyen-Khac F; Albaud B; Rapinat A; Dumont AG; Damm F; Popova T; Marais R; Fontenay M; Roman-Roman S; Bernard OA; Stern MH
Leukemia; 2014 Jun; 28(6):1355-7. PubMed ID: 24434863
[No Abstract] [Full Text] [Related]
2. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
[TBL] [Abstract][Full Text] [Related]
3. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.
Alsafadi S; Houy A; Battistella A; Popova T; Wassef M; Henry E; Tirode F; Constantinou A; Piperno-Neumann S; Roman-Roman S; Dutertre M; Stern MH
Nat Commun; 2016 Feb; 7():10615. PubMed ID: 26842708
[TBL] [Abstract][Full Text] [Related]
5. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
6. SF3B1 mutations in chronic lymphocytic leukemia.
Wan Y; Wu CJ
Blood; 2013 Jun; 121(23):4627-34. PubMed ID: 23568491
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells.
Wu X; Tschumper RC; Jelinek DF
Leukemia; 2013 Nov; 27(11):2264-7. PubMed ID: 23685408
[No Abstract] [Full Text] [Related]
8. Chronic lymphocytic leukemia with SF3B1 mutation.
Quesada V; Ramsay AJ; Lopez-Otin C
N Engl J Med; 2012 Jun; 366(26):2530. PubMed ID: 22738114
[No Abstract] [Full Text] [Related]
9. NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.
Mansouri L; Cahill N; Gunnarsson R; Smedby KE; Tjönnfjord E; Hjalgrim H; Juliusson G; Geisler C; Rosenquist R
Leukemia; 2013 Feb; 27(2):512-4. PubMed ID: 23138133
[No Abstract] [Full Text] [Related]
10. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
11. Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia.
Schwaederlé M; Ghia E; Rassenti LZ; Obara M; Dell'Aquila ML; Fecteau JF; Kipps TJ
Leukemia; 2013 Apr; 27(5):1214-7. PubMed ID: 23337928
[No Abstract] [Full Text] [Related]
12. Lack of SF3B1 R625 mutations in cutaneous melanoma.
Schilling B; Bielefeld N; Sucker A; Hillen U; Zimmer L; Schadendorf D; Zeschnigk M; Griewank KG
Diagn Pathol; 2013 May; 8():87. PubMed ID: 23694694
[TBL] [Abstract][Full Text] [Related]
13. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications.
Damm F; Thol F; Kosmider O; Kade S; Löffeld P; Dreyfus F; Stamatoullas-Bastard A; Tanguy-Schmidt A; Beyne-Rauzy O; de Botton S; Guerci-Bresler A; Göhring G; Schlegelberger B; Ganser A; Bernard OA; Fontenay M; Heuser M
Leukemia; 2012 May; 26(5):1137-40. PubMed ID: 22064355
[No Abstract] [Full Text] [Related]
14. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.
Martin M; Maßhöfer L; Temming P; Rahmann S; Metz C; Bornfeld N; van de Nes J; Klein-Hitpass L; Hinnebusch AG; Horsthemke B; Lohmann DR; Zeschnigk M
Nat Genet; 2013 Aug; 45(8):933-6. PubMed ID: 23793026
[TBL] [Abstract][Full Text] [Related]
15. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Visconte V; Rogers HJ; Singh J; Barnard J; Bupathi M; Traina F; McMahon J; Makishima H; Szpurka H; Jankowska A; Jerez A; Sekeres MA; Saunthararajah Y; Advani AS; Copelan E; Koseki H; Isono K; Padgett RA; Osman S; Koide K; O'Keefe C; Maciejewski JP; Tiu RV
Blood; 2012 Oct; 120(16):3173-86. PubMed ID: 22826563
[TBL] [Abstract][Full Text] [Related]
16. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.
Küsters-Vandevelde HV; Creytens D; van Engen-van Grunsven AC; Jeunink M; Winnepenninckx V; Groenen PJ; Küsters B; Wesseling P; Blokx WA; Prinsen CF
Acta Neuropathol Commun; 2016 Jan; 4():5. PubMed ID: 26769193
[TBL] [Abstract][Full Text] [Related]
17. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
Rossi D; Rasi S; Spina V; Fangazio M; Monti S; Greco M; Ciardullo C; Famà R; Cresta S; Bruscaggin A; Laurenti L; Martini M; Musto P; Forconi F; Marasca R; Larocca LM; Foà R; Gaidano G
Br J Haematol; 2012 Aug; 158(3):426-9. PubMed ID: 22571487
[No Abstract] [Full Text] [Related]
18. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract][Full Text] [Related]
19. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
[TBL] [Abstract][Full Text] [Related]
20. Spliceosome mutations in hematopoietic malignancies.
Hahn CN; Scott HS
Nat Genet; 2011 Dec; 44(1):9-10. PubMed ID: 22200771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]